| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | LUMENIS LTD | 245 | 0 | 0.00% | ||
| 2 | ALCOBRA LTD | 200 | 1,000 | 0.00% | ||
| 3 | SPECTRUM PHARMACEUTICALS INC COM | 50,000 | 304,000 | 0.03% | ||
| 4 | BIOLINERX LTD | 193,284 | 408,000 | 0.04% | ||
| 5 | SAPIENS INTL CORP N V SHS NEW | 56,420 | 463,000 | 0.05% | ||
| 6 | OHR PHARMACEUTICAL INC | 187,500 | 476,000 | 0.05% | ||
| 7 | ACHILLION PHARMACEUTICALS IN | 65,538 | 646,000 | 0.07% | ||
| 8 | MAST THERAPEUTICS INC COM | 1,374,900 | 667,000 | 0.07% | ||
| 9 | ELEVEN BIOTHERAPEUTICS INC | 87,110 | 777,000 | 0.08% | ||
| 10 | JUNO THERAPEUTICS INC COM | 15,000 | 910,000 | 0.09% | ||
| 11 | AURIS MED HLDG AG | 186,300 | 997,000 | 0.10% | ||
| 12 | PALATIN TECHNOLOGIES INC COM | 1,040,266 | 1,061,000 | 0.11% | ||
| 13 | CYMABAY THERAPEUTICS INC | 157,179 | 1,088,000 | 0.11% | ||
| 14 | IMMUNOMEDICS INCORPORATED | 300,000 | 1,149,000 | 0.12% | ||
| 15 | HERON THERAPEUTICS INC COM | 79,900 | 1,163,000 | 0.12% | ||
| 16 | SAGENT PHARMACEUTICALS INC | 50,000 | 1,163,000 | 0.12% | ||
| 17 | STEMLINE THERAPEUTICS INC | 80,957 | 1,171,000 | 0.12% | ||
| 18 | Aldeyra Therapeutics Inc | 115,000 | 1,194,000 | 0.12% | ||
| 19 | Ascendis Pharma | 70,000 | 1,215,000 | 0.13% | ||
| 20 | EXELIXIS INC | 500,000 | 1,285,000 | 0.13% | ||
| 21 | ASSEMBLY BIOSCIENCES INC | 100,000 | 1,324,000 | 0.14% | ||
| 22 | NEWLINK GENETICS CORP COM | 25,000 | 1,368,000 | 0.14% | ||
| 23 | MEDGENICS INC | 175,000 | 1,411,000 | 0.15% | ||
| 24 | GENOCEA BIOSCIENCES INC | 124,200 | 1,473,000 | 0.15% | ||
| 25 | GALECTIN THERAPEUTICS INC COM | 450,000 | 1,508,000 | 0.16% | ||
| 26 | OCERA THERAPEUTICS INC | 321,254 | 1,513,000 | 0.16% | ||
| 27 | GENVEC INC | 528,325 | 1,559,000 | 0.16% | ||
| 28 | MANNKIND CORP | 3,000 | 1,560,000 | 0.16% | Put | |
| 29 | CONATUS PHARMACEUTICALS INC | 220,000 | 1,566,000 | 0.16% | ||
| 30 | TOKAI PHARMACEUTICALS INC COM | 146,341 | 1,654,000 | 0.17% | ||
| 31 | CELLECTIS S A | 50,000 | 1,729,000 | 0.18% | ||
| 32 | GENTHERM INC | 34,550 | 1,745,000 | 0.18% | ||
| 33 | FOAMIX PHARMACEUTICALS LTD | 200,000 | 1,850,000 | 0.19% | ||
| 34 | TRANSITION THERAPEUTICS INC | 272,906 | 1,864,000 | 0.19% | ||
| 35 | ZOSANO PHARMA CORP | 184,619 | 1,866,000 | 0.19% | ||
| 36 | MACROGENICS INC | 60,000 | 1,882,000 | 0.20% | ||
| 37 | ELLOMAY CAPITAL LIMITED | 221,678 | 1,884,000 | 0.20% | ||
| 38 | UNION PAC CORP | 17,489 | 1,894,000 | 0.20% | ||
| 39 | Marinus Pharmaceuticals Inc | 213,533 | 1,920,000 | 0.20% | ||
| 40 | TRILLIUM THERAPEUTICS INC | 95,000 | 1,922,000 | 0.20% | ||
| 41 | STERICYCLE INC | 14,500 | 2,036,000 | 0.21% | ||
| 42 | WABTEC CORP | 21,500 | 2,043,000 | 0.21% | ||
| 43 | PRICELINE GRP INC | 1,820 | 2,119,000 | 0.22% | ||
| 44 | ISHARES TR | 76,000 | 2,145,000 | 0.22% | ||
| 45 | INOTEK PHARMACEUTICALS CORP | 400,000 | 2,168,000 | 0.23% | ||
| 46 | SUMMIT THERAPEUTICS PLC | 175,000 | 2,168,000 | 0.23% | ||
| 47 | SANGAMO THERAPEUTICS INCORPORATED | 140,000 | 2,195,000 | 0.23% | ||
| 48 | THERAPEUTICSMD INC | 365,000 | 2,208,000 | 0.23% | ||
| 49 | SNAP ON INC | 15,340 | 2,256,000 | 0.23% | ||
| 50 | AVALANCHE BIOTECHNOLOGIES IN | 60,000 | 2,431,000 | 0.25% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001178913-15-001551, filed 2015.05.11).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
